Literature DB >> 7037967

A rapid antibody assay system for screening hybridoma cultures.

D P Lane, E B Lane.   

Abstract

A procedure for the rapid qualitative assay of large numbers of antibody samples is described which has been extensively used for primary screening of mouse spleen cell-myeloma hybrids making monoclonal antibodies. It is a handling modification of standard indirect immunofluorescence of immunoperoxidase techniques which involves in situ localisation of antigens in a fixed and dried monolayer of cells on plastic culture dishes. The method is quick and economical and does not depend on hazardous reagents or specialised detection equipment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7037967     DOI: 10.1016/0022-1759(81)90286-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Monoclonal antibody analysis of p53 expression in normal and transformed cells.

Authors:  J W Yewdell; J V Gannon; D P Lane
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

2.  Functional analysis of a simian virus 40 super T-antigen.

Authors:  C E Clayton; M Lovett; P W Rigby
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

3.  A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions.

Authors:  W A Muller; C M Ratti; S L McDonnell; Z A Cohn
Journal:  J Exp Med       Date:  1989-08-01       Impact factor: 14.307

4.  The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine.

Authors:  Saurabh Jain; Luca Aresu; Stefano Comazzi; Jianguo Shi; Erin Worrall; John Clayton; William Humphries; Sandra Hemmington; Paul Davis; Euan Murray; Asmare A Limeneh; Kathryn Ball; Eva Ruckova; Petr Muller; Borek Vojtesek; Robin Fahraeus; David Argyle; Ted R Hupp
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

5.  B-less: a strain of profoundly B cell-deficient mice expressing a human lambda transgene.

Authors:  T J Vasicek; D A Levinson; E V Schmidt; J Campos-Torres; P Leder
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.